News | Prostate Cancer | February 12, 2019
February 12, 2019 — Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound...
News | Proton Therapy | January 28, 2019
January 28, 2019 — IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai,...
News | Brachytherapy Systems | January 04, 2019
January 4, 2018 — Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported...
Videos | Artificial Intelligence | November 28, 2018
This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data...
News | Prostate Cancer | November 19, 2018
November 19, 2018 — Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of...
October 31, 2018 — An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized...
News | Brachytherapy Systems | October 31, 2018
October 31, 2018 — A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure...
Feature | Prostate Cancer | October 30, 2018
October 30, 2018 — While popular beliefs and population data suggest that African-American men are at higher risk of...
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of prostate cancer after...
News | Prostate Cancer | October 17, 2018
October 17, 2018 — Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the...
News | Prostate Cancer | October 12, 2018
October 12, 2018 — Three prominent medical societies issued a new clinical guideline for physicians treating men with...
September 27, 2018 — Accuray Inc. announced that published data from two prospective, multi-center studies using...
News | Prostate Cancer | September 19, 2018
September 19, 2018 — Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based...

Amar Kishan, M.D.
News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the...
September 7, 2018 — Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-...

Image courtesy of IBA
Feature | Radiation Oncology | September 07, 2018 | By Jeff Zagoudis
According to the latest statistics from the American Cancer Society (ACS), almost 165,000 new cases of prostate cancer...
News | Ultrasound Imaging | August 10, 2018
August 10, 2018 — Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American...
July 16, 2018 — Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now...

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.
68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.
News | PET Imaging | June 29, 2018
June 29, 2018 — In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high...
Technology | Focused Ultrasound Therapy | June 19, 2018
June 19, 2018 — EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...